These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17469345)

  • 21. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 22. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From the metabolic syndrome to the concept of global cardiometabolic risk].
    Nádas J; Jermendy G
    Orv Hetil; 2009 May; 150(18):821-9. PubMed ID: 19383573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The metabolic syndrome and insulin resistance].
    Kotani K; Kaku K
    Nihon Rinsho; 2005 Aug; 63(8):1485-91. PubMed ID: 16101244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The metabolic syndrome. Part I: definitions and diagnostic criteria for its identification. Epidemiology and relationship with cardiovascular and type 2 diabetes risk].
    Pacholczyk M; Ferenc T; Kowalski J
    Postepy Hig Med Dosw (Online); 2008 Oct; 62():530-42. PubMed ID: 18936729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel component of the metabolic syndrome: the oxidative stress.
    Hopps E; Noto D; Caimi G; Averna MR
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):72-7. PubMed ID: 19747805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. History of preeclampsia is more predictive of cardiometabolic and cardiovascular risk factors than obesity.
    Heidema WM; Scholten RR; Lotgering FK; Spaanderman ME
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():189-93. PubMed ID: 26433185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
    Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
    Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial dysfunction in metabolic syndrome.
    Cozma A; Orăşan O; Sâmpelean D; Fodor A; Vlad C; Negrean V; Rednic N; Zdrenghea D
    Rom J Intern Med; 2009; 47(2):133-40. PubMed ID: 20067163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome.
    O'Gorman CS; Syme C; Lang J; Bradley TJ; Wells GD; Hamilton JK
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):907-13. PubMed ID: 23106295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.
    Marotta T; Russo BF; Ferrara LA
    Obesity (Silver Spring); 2010 Aug; 18(8):1608-13. PubMed ID: 20019684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease under the influence of excess visceral fat.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity indices and major components of metabolic syndrome in young adult Arab subjects.
    Al-Shayji IA; Akanji AO
    Ann Nutr Metab; 2004; 48(1):1-7. PubMed ID: 14639040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.
    Cruz ML; Weigensberg MJ; Huang TT; Ball G; Shaibi GQ; Goran MI
    J Clin Endocrinol Metab; 2004 Jan; 89(1):108-13. PubMed ID: 14715836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.